0	0	1999-09-22	CD	O	O	B-Num
0	1	21	CD	O	O	B-Num
0	2	:	:	O	O	I-Num
0	3	11	CD	O	B-NP	I-Num
0	4	RESEARCHERS	NNS	O	I-NP	B-ProfTitle
0	5	TURN	NNP	O	O	O
0	6	MARROW	NNP	O	O	O
0	7	INTO	NNP	O	O	O
0	8	MUSCLE	NNP	O	O	O

1	0	In	IN	O	B-PP	O
1	1	unexpected	JJ	O	B-NP	O
1	2	testimony	NN	O	I-NP	O
1	3	to	TO	O	B-PP	O
1	4	the	DT	O	B-NP	O
1	5	versatility	NN	O	I-NP	O
1	6	of	IN	O	B-PP	O
1	7	the	DT	O	B-NP	O
1	8	body	NN	O	I-NP	O
1	9	's	POS	O	B-NP	O
1	10	cells	NNS	O	I-NP	O
1	11	COMMA	COMMA	O	O	O
1	12	researchers	NNS	O	B-NP	B-ProfTitle
1	13	have	VBP	O	B-VP	O
1	14	found	VBN	O	I-VP	O
1	15	they	PRP	O	B-NP	O
1	16	can	MD	O	B-VP	O
1	17	make	VB	O	I-VP	O
1	18	bone	NN	O	B-NP	O
1	19	marrow	NN	O	I-NP	O
1	20	cells	NNS	O	I-NP	O
1	21	turn	VBP	O	B-VP	O
1	22	into	IN	O	B-PP	O
1	23	muscle	NN	O	B-NP	O
1	24	COMMA	COMMA	O	O	O
1	25	causing	VBG	O	B-VP	O
1	26	mice	NNS	O	B-NP	B-Animal
1	27	with	IN	O	B-PP	O
1	28	muscular	JJ	O	B-NP	B-Medical
1	29	dystrophy	NN	O	I-NP	I-Medical
1	30	to	TO	O	B-VP	O
1	31	produce	VB	O	I-VP	O
1	32	correctly	RB	O	B-NP	O
1	33	working	VBG	O	I-NP	O
1	34	muscle	NN	O	I-NP	O
1	35	cells	NNS	O	I-NP	O
1	36	.	.	O	O	O

2	0	The	DT	O	B-NP	O
2	1	experiment	NN	O	I-NP	O
2	2	suggests	VBZ	O	B-VP	O
2	3	that	IN	O	O	O
2	4	a	DT	O	B-NP	O
2	5	form	NN	O	I-NP	O
2	6	of	IN	O	B-PP	O
2	7	bone	NN	O	B-NP	O
2	8	marrow	NN	O	I-NP	O
2	9	transplant	NN	O	I-NP	O
2	10	_	NN	O	I-NP	O
2	11	a	DT	O	B-NP	O
2	12	well	RB	O	I-NP	O
2	13	established	VBN	O	I-NP	O
2	14	surgical	JJ	O	I-NP	B-Medical
2	15	procedure	NN	O	I-NP	O
2	16	_	NN	O	I-NP	O
2	17	could	MD	O	B-VP	O
2	18	in	IN	O	B-PP	O
2	19	principle	NN	O	B-NP	O
2	20	treat	VBP	O	B-VP	O
2	21	patients	NNS	O	B-NP	O
2	22	with	IN	O	B-PP	O
2	23	a	DT	O	B-NP	O
2	24	variety	NN	O	I-NP	O
2	25	of	IN	O	B-PP	O
2	26	diseases	NNS	O	B-NP	O
2	27	.	.	O	O	O

3	0	The	DT	O	B-NP	O
3	1	immediate	JJ	O	I-NP	O
3	2	relevance	NN	O	I-NP	O
3	3	of	IN	O	B-PP	O
3	4	the	DT	O	B-NP	O
3	5	new	JJ	O	I-NP	O
3	6	result	NN	O	I-NP	O
3	7	is	VBZ	O	B-VP	O
3	8	for	IN	O	B-PP	O
3	9	muscular	JJ	O	B-NP	B-Medical
3	10	dystrophy	NN	O	I-NP	I-Medical
3	11	COMMA	COMMA	O	O	O
3	12	a	DT	O	B-NP	O
3	13	set	VBD	O	I-NP	O
3	14	of	IN	O	B-PP	O
3	15	diseases	NNS	O	B-NP	O
3	16	said	VBD	O	B-VP	O
3	17	by	IN	O	B-PP	O
3	18	the	DT	O	B-NP	O
3	19	Muscular	NNP	O	I-NP	B-OrgCorp
3	20	Dystrophy	NNP	O	I-NP	I-OrgCorp
3	21	Association	NNP	O	I-NP	I-OrgCorp
3	22	to	TO	O	B-VP	O
3	23	affect	VB	O	I-VP	O
3	24	250COMMA000	CD	O	B-NP	B-Num
3	25	Americans	NNPS	O	I-NP	B-LangRace
3	26	.	.	O	O	O

4	0	Researchers	NNS	O	B-NP	B-ProfTitle
4	1	have	VBP	O	B-VP	O
4	2	tried	VBN	O	I-VP	O
4	3	to	TO	O	I-VP	O
4	4	treat	VB	O	I-VP	O
4	5	the	DT	O	B-NP	O
4	6	disease	NN	O	I-NP	B-Medical
4	7	with	IN	O	B-PP	O
4	8	injections	NNS	O	B-NP	O
4	9	of	IN	O	B-PP	O
4	10	normal	JJ	O	B-NP	O
4	11	muscle	NN	O	I-NP	O
4	12	cells	NNS	O	I-NP	O
4	13	from	IN	O	B-PP	O
4	14	a	DT	O	O	O
4	15	relative	JJ	O	O	O
4	16	COMMA	COMMA	O	O	O
4	17	but	CC	O	O	O
4	18	the	DT	O	B-NP	O
4	19	cells	NNS	O	I-NP	O
4	20	do	VBP	O	B-VP	O
4	21	not	RB	O	I-VP	O
4	22	spread	VBN	O	I-VP	O
4	23	beyond	IN	O	B-PP	O
4	24	the	DT	O	B-NP	O
4	25	site	NN	O	I-NP	O
4	26	of	IN	O	B-PP	O
4	27	injection	NN	O	B-NP	B-Medical
4	28	.	.	O	O	O

5	0	In	IN	O	B-PP	O
5	1	a	DT	O	B-NP	O
5	2	report	NN	O	I-NP	O
5	3	the	DT	O	B-NP	O
5	4	Thursday	NNP	O	I-NP	B-Date
5	5	issue	NN	O	I-NP	O
5	6	of	IN	O	B-PP	O
5	7	the	DT	O	B-NP	O
5	8	journal	NN	O	I-NP	B-Jour
5	9	Nature	NN	O	I-NP	O
5	10	COMMA	COMMA	O	O	O
5	11	biologists	NNS	O	B-NP	O
5	12	from	IN	O	B-PP	O
5	13	Children	NNP	O	B-NP	B-Loc
5	14	's	POS	O	B-NP	O
5	15	Hospital	NNP	O	I-NP	O
5	16	in	IN	O	B-PP	O
5	17	Boston	NNP	O	B-NP	B-LocCit
5	18	say	VBP	O	B-VP	O
5	19	they	PRP	O	B-NP	O
5	20	gave	VBD	O	B-VP	O
5	21	bone	NN	O	B-NP	O
5	22	marrow	NN	O	I-NP	O
5	23	transplants	NNS	O	I-NP	O
5	24	from	IN	O	B-PP	O
5	25	normal	JJ	O	B-NP	O
5	26	mice	NNS	O	I-NP	B-Animal
5	27	to	TO	O	B-PP	O
5	28	dystrophic	JJ	O	B-NP	O
5	29	mice	NNS	O	I-NP	B-Animal
5	30	COMMA	COMMA	O	O	O
5	31	and	CC	O	O	O
5	32	that	IN	O	O	O
5	33	12	CD	O	B-NP	B-Num
5	34	weeks	NNS	O	I-NP	I-Num
5	35	later	RB	O	O	O
5	36	about	IN	O	O	O
5	37	10	CD	O	B-NP	B-NumPercent
5	38	percent	NN	O	I-NP	I-NumPercent
5	39	of	IN	O	B-PP	O
5	40	the	DT	O	B-NP	O
5	41	muscle	NN	O	I-NP	O
5	42	fibers	NNS	O	I-NP	O
5	43	in	IN	O	B-PP	O
5	44	the	DT	O	B-NP	O
5	45	diseased	JJ	O	I-NP	O
5	46	animals	NNS	O	I-NP	B-Animal
5	47	were	VBD	O	B-VP	O
5	48	making	VBG	O	I-VP	O
5	49	the	DT	O	B-NP	O
5	50	correct	JJ	O	I-NP	O
5	51	form	NN	O	I-NP	O
5	52	of	IN	O	B-PP	O
5	53	dystrophin	NN	O	B-NP	O
5	54	COMMA	COMMA	O	O	O
5	55	the	DT	O	B-NP	O
5	56	protein	NN	O	I-NP	B-Medical
5	57	that	WDT	O	B-NP	O
5	58	is	VBZ	O	B-VP	O
5	59	genetically	RB	O	O	O
5	60	defective	JJ	O	O	O
5	61	in	IN	O	B-PP	O
5	62	Duchenne	NNP	O	B-NP	B-Loc
5	63	's	POS	O	B-NP	O
5	64	muscular	JJ	O	I-NP	B-Medical
5	65	dystrophy	NN	O	I-NP	I-Medical
5	66	.	.	O	O	O

6	0	The	DT	O	B-NP	O
6	1	treated	VBN	O	I-NP	O
6	2	mice	NNS	O	I-NP	B-Animal
6	3	did	VBD	O	B-VP	O
6	4	not	RB	O	I-VP	O
6	5	appear	VB	O	I-VP	O
6	6	stronger	JJR	O	O	O
6	7	COMMA	COMMA	O	O	O
6	8	said	VBD	O	B-VP	O
6	9	Dr.	NNP	O	B-NP	B-ProfTitle
6	10	Louis	NNP	O	I-NP	B-Peop
6	11	M.	NNP	O	I-NP	I-Peop
6	12	Kunkel	NNP	O	I-NP	I-Peop
6	13	COMMA	COMMA	O	O	O
6	14	one	CD	O	B-NP	B-Num
6	15	of	IN	O	B-PP	O
6	16	the	DT	O	B-NP	O
6	17	authors	NNS	O	I-NP	B-ProfTitle
6	18	of	IN	O	B-PP	O
6	19	the	DT	O	B-NP	O
6	20	research	NN	O	I-NP	O
6	21	COMMA	COMMA	O	O	O
6	22	because	IN	O	O	O
6	23	a	DT	O	B-NP	O
6	24	10	CD	O	I-NP	B-NumPercent
6	25	percent	NN	O	I-NP	I-NumPercent
6	26	replacement	NN	O	I-NP	O
6	27	is	VBZ	O	O	O
6	28	not	RB	O	O	O
6	29	therapeutically	RB	O	O	O
6	30	useful	JJ	O	O	O
6	31	.	.	O	O	O

7	0	But	CC	O	O	O
7	1	Kunkel	NNP	O	B-NP	B-Peop
7	2	and	CC	O	O	O
7	3	his	PP$	O	B-NP	O
7	4	colleague	NN	O	I-NP	O
7	5	COMMA	COMMA	O	O	O
7	6	Dr.	NNP	O	B-NP	B-ProfTitle
7	7	Richard	NNP	O	I-NP	B-Peop
7	8	C.	NNP	O	I-NP	I-Peop
7	9	Mulligan	NNP	O	I-NP	I-Peop
7	10	COMMA	COMMA	O	O	O
7	11	believe	VBP	O	B-VP	O
7	12	their	PP$	O	B-NP	O
7	13	work	NN	O	I-NP	O
7	14	suggests	VBZ	O	B-VP	O
7	15	ways	NNS	O	B-NP	O
7	16	of	IN	O	B-PP	O
7	17	developing	VBG	O	B-VP	O
7	18	possible	JJ	O	B-NP	O
7	19	treatments	NNS	O	I-NP	O
7	20	.	.	O	O	O

8	0	That	DT	O	B-NP	O
8	1	view	NN	O	I-NP	O
8	2	is	VBZ	O	B-VP	O
8	3	shared	VBN	O	I-VP	O
8	4	by	IN	O	B-PP	O
8	5	other	JJ	O	B-NP	O
8	6	experts	NNS	O	I-NP	O
8	7	.	.	O	O	O

9	0	``	``	O	O	O
9	1	The	DT	O	B-NP	O
9	2	integration	NN	O	I-NP	O
9	3	of	IN	O	B-PP	O
9	4	these	DT	O	B-NP	O
9	5	cells	NNS	O	I-NP	O
9	6	with	IN	O	B-PP	O
9	7	the	DT	O	B-NP	O
9	8	muscle	NN	O	I-NP	O
9	9	cells	NNS	O	I-NP	O
9	10	is	VBZ	O	B-VP	O
9	11	a	DT	O	B-NP	O
9	12	great	JJ	O	I-NP	O
9	13	finding	NN	O	I-NP	O
9	14	because	IN	O	O	O
9	15	it	PRP	O	B-NP	O
9	16	really	RB	O	O	O
9	17	does	VBZ	O	B-VP	O
9	18	open	VB	O	I-VP	O
9	19	up	IN	O	B-PP	O
9	20	the	DT	O	B-NP	O
9	21	possibility	NN	O	I-NP	O
9	22	of	IN	O	B-PP	O
9	23	therapy	NN	O	B-NP	B-Medical
9	24	for	IN	O	B-PP	O
9	25	these	DT	O	B-NP	O
9	26	patientsCOMMA	NN	O	I-NP	O
9	27	''	''	O	O	O
9	28	said	VBD	O	B-VP	O
9	29	Dr.	NNP	O	B-NP	B-ProfTitle
9	30	Mark	NNP	O	I-NP	B-Peop
9	31	F.	NNP	O	I-NP	I-Peop
9	32	Pittenger	NNP	O	I-NP	I-Peop
9	33	COMMA	COMMA	O	O	O
9	34	a	DT	O	B-NP	O
9	35	biologist	NN	O	I-NP	B-ProfTitle
9	36	at	IN	O	B-PP	O
9	37	Osiris	NNP	O	B-NP	B-Jour
9	38	Therapeutics	NNPS	O	I-NP	O
9	39	in	IN	O	B-PP	O
9	40	Baltimore	NNP	O	B-NP	B-LocCit
9	41	who	WP	O	B-NP	O
9	42	is	VBZ	O	B-VP	O
9	43	working	VBG	O	I-VP	O
9	44	on	IN	O	B-PP	O
9	45	muscle	NN	O	B-NP	O
9	46	replacement	NN	O	I-NP	O
9	47	techniques	NNS	O	I-NP	O
9	48	.	.	O	O	O

10	0	The	DT	O	B-NP	O
10	1	new	JJ	O	I-NP	O
10	2	finding	NN	O	I-NP	O
10	3	extends	VBZ	O	B-VP	O
10	4	the	DT	O	B-NP	O
10	5	fast	RB	O	I-NP	O
10	6	growing	VBG	O	I-NP	O
10	7	body	NN	O	I-NP	O
10	8	of	IN	O	B-PP	O
10	9	knowledge	NN	O	B-NP	O
10	10	about	IN	O	O	O
10	11	stem	VBP	O	B-VP	B-Jour
10	12	cells	NNS	O	B-NP	I-Jour
10	13	COMMA	COMMA	O	O	O
10	14	the	DT	O	B-NP	O
10	15	long	JJ	O	I-NP	O
10	16	hidden	VBN	O	I-NP	O
10	17	source	NN	O	I-NP	O
10	18	of	IN	O	B-PP	O
10	19	the	DT	O	B-NP	O
10	20	body	NN	O	I-NP	O
10	21	's	POS	O	B-NP	O
10	22	ability	NN	O	I-NP	O
10	23	to	TO	O	B-VP	O
10	24	renew	VB	O	I-VP	O
10	25	and	CC	O	O	O
10	26	repair	VB	O	O	O
10	27	its	PP$	O	B-NP	O
10	28	tissues	NNS	O	I-NP	O
10	29	.	.	O	O	O

11	0	Unlike	IN	O	B-PP	O
11	1	mature	JJ	O	B-NP	O
11	2	cells	NNS	O	I-NP	O
11	3	COMMA	COMMA	O	O	O
11	4	which	WDT	O	B-NP	O
11	5	are	VBP	O	O	O
11	6	permanently	RB	O	O	O
11	7	committed	VBN	O	O	O
11	8	to	TO	O	B-PP	O
11	9	their	PP$	O	B-NP	O
11	10	fate	NN	O	I-NP	O
11	11	COMMA	COMMA	O	O	O
11	12	stem	VBP	O	B-VP	B-Jour
11	13	cells	NNS	O	B-NP	I-Jour
11	14	can	MD	O	O	O
11	15	both	DT	O	O	O
11	16	renew	VB	O	B-VP	O
11	17	themselves	PRP	O	B-NP	O
11	18	as	RB	O	O	O
11	19	well	RB	O	O	O
11	20	as	IN	O	O	O
11	21	create	VBP	O	B-VP	O
11	22	new	JJ	O	B-NP	O
11	23	cells	NNS	O	I-NP	O
11	24	of	IN	O	B-PP	O
11	25	whatever	WDT	O	B-NP	O
11	26	tissue	NN	O	I-NP	O
11	27	they	PRP	O	B-NP	O
11	28	belong	VBP	O	B-VP	O
11	29	to	TO	O	B-PP	O
11	30	.	.	O	O	O

12	0	Mulligan	NNP	O	B-NP	B-Peop
12	1	said	VBD	O	B-VP	O
12	2	that	IN	O	O	O
12	3	a	DT	O	B-NP	O
12	4	colleague	NN	O	I-NP	O
12	5	COMMA	COMMA	O	O	O
12	6	Dr.	NNP	O	B-NP	B-ProfTitle
12	7	Margaret	NNP	O	I-NP	B-Peop
12	8	A.	NNP	O	I-NP	I-Peop
12	9	Goodell	NNP	O	I-NP	I-Peop
12	10	COMMA	COMMA	O	O	O
12	11	learned	VBD	O	B-VP	O
12	12	through	IN	O	B-PP	O
12	13	a	DT	O	B-NP	O
12	14	lucky	JJ	O	I-NP	O
12	15	discovery	NN	O	I-NP	O
12	16	five	CD	O	B-NP	B-Num
12	17	years	NNS	O	I-NP	B-Date
12	18	ago	IN	O	B-PP	O
12	19	how	WRB	O	O	O
12	20	to	TO	O	B-VP	O
12	21	isolate	VB	O	I-VP	O
12	22	a	DT	O	B-NP	O
12	23	special	JJ	O	I-NP	O
12	24	sub-population	NN	O	I-NP	O
12	25	of	IN	O	B-PP	O
12	26	the	DT	O	B-NP	O
12	27	bone	NN	O	I-NP	O
12	28	marrow	NN	O	I-NP	O
12	29	stem	VBP	O	B-VP	B-Jour
12	30	cells	NNS	O	B-NP	I-Jour
12	31	that	DT	O	B-NP	O
12	32	form	VBP	O	B-VP	O
12	33	the	DT	O	B-NP	O
12	34	blood	NN	O	I-NP	O
12	35	system	NN	O	I-NP	O
12	36	.	.	O	O	O

13	0	These	DT	O	B-NP	O
13	1	cells	NNS	O	I-NP	O
13	2	may	MD	O	B-VP	O
13	3	be	VB	O	I-VP	O
13	4	ancestral	JJ	O	O	O
13	5	to	TO	O	B-PP	O
13	6	the	DT	O	B-NP	O
13	7	ordinary	JJ	O	I-NP	O
13	8	bone	NN	O	I-NP	O
13	9	marrow	NN	O	I-NP	O
13	10	stem	VBP	O	B-VP	B-Jour
13	11	cells	NNS	O	B-NP	I-Jour
13	12	and	CC	O	O	O
13	13	thus	RB	O	O	O
13	14	possess	VBP	O	B-VP	O
13	15	greater	JJR	O	B-NP	O
13	16	versatility	NN	O	I-NP	O
13	17	COMMA	COMMA	O	O	O
13	18	though	IN	O	O	O
13	19	this	DT	O	B-NP	O
13	20	has	VBZ	O	B-VP	O
13	21	not	RB	O	I-VP	O
13	22	been	VBN	O	I-VP	O
13	23	proved	VBN	O	I-VP	O
13	24	.	.	O	O	O

14	0	It	PRP	O	B-NP	O
14	1	is	VBZ	O	B-VP	O
14	2	these	DT	O	B-NP	O
14	3	presumed	VBN	O	I-NP	O
14	4	ancestral	JJ	O	I-NP	O
14	5	bone	NN	O	I-NP	O
14	6	marrow	NN	O	I-NP	O
14	7	stem	VBP	O	B-VP	B-Jour
14	8	cells	NNS	O	B-NP	I-Jour
14	9	that	WDT	O	B-NP	O
14	10	were	VBD	O	B-VP	O
14	11	used	VBN	O	I-VP	O
14	12	to	TO	O	B-VP	O
14	13	treat	VB	O	I-VP	O
14	14	the	DT	O	B-NP	O
14	15	dystrophic	JJ	O	I-NP	O
14	16	mice	NNS	O	I-NP	B-Animal
14	17	COMMA	COMMA	O	O	O
14	18	which	WDT	O	B-NP	O
14	19	are	VBP	O	B-VP	O
14	20	animals	NNS	O	B-NP	B-Animal
14	21	whose	WP$	O	B-NP	O
14	22	dystrophin	NN	O	I-NP	O
14	23	gene	NN	O	I-NP	O
14	24	has	VBZ	O	B-VP	O
14	25	been	VBN	O	I-VP	O
14	26	removed	VBN	O	I-VP	O
14	27	so	RB	O	O	O
14	28	as	IN	O	O	O
14	29	to	TO	O	B-VP	O
14	30	mimic	VB	O	I-VP	O
14	31	the	DT	O	B-NP	O
14	32	human	JJ	O	I-NP	B-Animal
14	33	condition	NN	O	I-NP	O
14	34	.	.	O	O	O

15	0	In	IN	O	B-PP	O
15	1	a	DT	O	B-NP	O
15	2	parallel	JJ	O	I-NP	O
15	3	experiment	NN	O	I-NP	O
15	4	COMMA	COMMA	O	O	O
15	5	the	DT	O	B-NP	O
15	6	researchers	NNS	O	I-NP	B-ProfTitle
15	7	also	RB	O	O	O
15	8	used	VBD	O	B-VP	O
15	9	Dr.	NNP	O	B-NP	B-ProfTitle
15	10	Goodell	NNP	O	I-NP	B-Peop
15	11	's	POS	O	B-NP	O
15	12	technique	NN	O	I-NP	O
15	13	to	TO	O	B-VP	O
15	14	isolate	VB	O	I-VP	O
15	15	ancestral-type	JJ	O	B-NP	O
15	16	stem	VBP	O	B-VP	B-Jour
15	17	cells	NNS	O	B-NP	I-Jour
15	18	from	IN	O	B-PP	O
15	19	muscle	NN	O	B-NP	O
15	20	.	.	O	O	O

16	0	The	DT	O	B-NP	O
16	1	muscle-derived	JJ	O	I-NP	O
16	2	stem	NN	O	I-NP	B-Jour
16	3	cells	NNS	O	I-NP	I-Jour
16	4	could	MD	O	B-VP	O
16	5	also	RB	O	I-VP	O
16	6	repopulate	VB	O	I-VP	O
16	7	both	PDT	O	B-NP	O
16	8	the	DT	O	I-NP	O
16	9	bone	NN	O	I-NP	O
16	10	marrow	NN	O	I-NP	O
16	11	and	CC	O	I-NP	O
16	12	muscle	NN	O	I-NP	O
16	13	.	.	O	O	O

17	0	Many	JJ	O	B-NP	O
17	1	details	NNS	O	I-NP	O
17	2	of	IN	O	B-PP	O
17	3	this	DT	O	B-NP	O
17	4	complex	JJ	O	I-NP	O
17	5	experiment	NN	O	I-NP	O
17	6	have	VBP	O	B-VP	O
17	7	yet	RB	O	I-VP	O
17	8	to	TO	O	I-VP	O
17	9	be	VB	O	I-VP	O
17	10	worked	VBN	O	I-VP	O
17	11	out	IN	O	O	O
17	12	COMMA	COMMA	O	O	O
17	13	such	JJ	O	B-PP	O
17	14	as	IN	O	I-PP	O
17	15	the	DT	O	B-NP	O
17	16	exact	JJ	O	I-NP	O
17	17	relationship	NN	O	I-NP	O
17	18	between	IN	O	B-PP	O
17	19	the	DT	O	B-NP	O
17	20	ancestral	JJ	O	I-NP	O
17	21	cells	NNS	O	I-NP	O
17	22	derived	VBD	O	B-VP	O
17	23	from	IN	O	B-PP	O
17	24	bone	NN	O	B-NP	O
17	25	marrow	NN	O	I-NP	O
17	26	and	CC	O	B-PP	O
17	27	from	IN	O	B-PP	O
17	28	muscle	NN	O	B-NP	O
17	29	COMMA	COMMA	O	O	O
17	30	and	CC	O	O	O
17	31	their	PP$	O	B-NP	O
17	32	relationship	NN	O	I-NP	O
17	33	to	TO	O	B-PP	O
17	34	mesenchymal	NN	O	B-NP	O
17	35	stem	NN	O	I-NP	B-Jour
17	36	cells	NNS	O	I-NP	I-Jour
17	37	COMMA	COMMA	O	O	O
17	38	the	DT	O	B-NP	O
17	39	known	VBN	O	I-NP	O
17	40	progenitor	NN	O	I-NP	O
17	41	of	IN	O	B-PP	O
17	42	muscle	NN	O	B-NP	O
17	43	.	.	O	O	O

18	0	Pittenger	NNP	O	B-NP	B-Peop
18	1	said	VBD	O	B-VP	O
18	2	he	PRP	O	B-NP	O
18	3	believed	VBD	O	B-VP	O
18	4	the	DT	O	B-NP	O
18	5	ancestral-type	JJ	O	I-NP	O
18	6	cells	NNS	O	I-NP	O
18	7	must	MD	O	B-VP	O
18	8	first	RB	O	I-VP	B-Num
18	9	develop	VB	O	I-VP	O
18	10	into	IN	O	B-PP	O
18	11	mesenchymal	NN	O	B-NP	O
18	12	stem	VBP	O	B-VP	B-Jour
18	13	cells	NNS	O	B-NP	I-Jour
18	14	before	IN	O	B-PP	O
18	15	forming	VBG	O	B-VP	O
18	16	muscle	NN	O	B-NP	O
18	17	.	.	O	O	O

19	0	Both	DT	O	B-NP	O
19	1	Kunkel	NNP	O	I-NP	O
19	2	and	CC	O	I-NP	O
19	3	Mulligan	NNP	O	I-NP	O
19	4	hope	VBP	O	B-VP	O
19	5	to	TO	O	I-VP	O
19	6	develop	VB	O	I-VP	O
19	7	treatments	NNS	O	B-NP	O
19	8	for	IN	O	B-PP	O
19	9	muscular	JJ	O	B-NP	B-Medical
19	10	dystrophy	NN	O	I-NP	I-Medical
19	11	COMMA	COMMA	O	O	O
19	12	though	IN	O	O	O
19	13	in	IN	O	B-PP	O
19	14	different	JJ	O	B-NP	O
19	15	ways	NNS	O	I-NP	O
19	16	.	.	O	O	O

20	0	Kunkel	NNP	O	B-NP	B-Peop
20	1	COMMA	COMMA	O	O	O
20	2	who	WP	O	B-NP	O
20	3	has	VBZ	O	B-VP	O
20	4	been	VBN	O	I-VP	O
20	5	studying	VBG	O	I-VP	O
20	6	muscular	JJ	O	B-NP	B-Medical
20	7	dystrophy	NN	O	I-NP	I-Medical
20	8	for	IN	O	B-PP	O
20	9	18	CD	O	B-NP	B-Num
20	10	years	NNS	O	I-NP	I-Num
20	11	COMMA	COMMA	O	O	O
20	12	succeeded	VBN	O	B-VP	O
20	13	in	IN	O	B-PP	O
20	14	isolating	VBG	O	B-VP	O
20	15	the	DT	O	B-NP	O
20	16	dystrophin	NN	O	I-NP	O
20	17	gene	NN	O	I-NP	O
20	18	in	IN	O	B-PP	O
20	19	1986	CD	O	B-NP	B-Date
20	20	.	.	O	O	O

21	0	He	PRP	O	B-NP	O
21	1	believes	VBZ	O	B-VP	O
21	2	the	DT	O	B-NP	O
21	3	ideal	JJ	O	I-NP	O
21	4	treatment	NN	O	I-NP	O
21	5	suggested	VBD	O	B-VP	O
21	6	by	IN	O	B-PP	O
21	7	the	DT	O	B-NP	O
21	8	new	JJ	O	I-NP	O
21	9	approach	NN	O	I-NP	O
21	10	would	MD	O	B-VP	O
21	11	be	VB	O	I-VP	O
21	12	to	TO	O	B-VP	O
21	13	take	VB	O	I-VP	O
21	14	a	DT	O	B-NP	O
21	15	sample	NN	O	I-NP	O
21	16	of	IN	O	B-PP	O
21	17	a	DT	O	B-NP	O
21	18	patient	NN	O	I-NP	B-Medical
21	19	's	POS	O	B-NP	O
21	20	own	JJ	O	I-NP	O
21	21	muscle	NN	O	I-NP	O
21	22	COMMA	COMMA	O	O	O
21	23	isolate	VBP	O	B-VP	O
21	24	the	DT	O	B-NP	O
21	25	ancestral	JJ	O	I-NP	O
21	26	muscle	NN	O	I-NP	O
21	27	stem	VBP	O	B-VP	B-Jour
21	28	cells	NNS	O	B-NP	I-Jour
21	29	and	CC	O	O	O
21	30	treat	VBP	O	B-VP	O
21	31	them	PRP	O	B-NP	O
21	32	outside	IN	O	B-PP	B-Medical
21	33	the	DT	O	B-NP	I-Medical
21	34	body	NN	O	I-NP	I-Medical
21	35	with	IN	O	B-PP	O
21	36	the	DT	O	B-NP	O
21	37	correct	JJ	O	I-NP	O
21	38	version	NN	O	I-NP	O
21	39	of	IN	O	B-PP	O
21	40	the	DT	O	B-NP	O
21	41	dystrophin	NN	O	I-NP	O
21	42	gene	NN	O	I-NP	O
21	43	.	.	O	O	O

22	0	The	DT	O	B-NP	O
22	1	treated	VBN	O	I-NP	O
22	2	cells	NNS	O	I-NP	O
22	3	would	MD	O	B-VP	O
22	4	then	RB	O	I-VP	O
22	5	be	VB	O	I-VP	O
22	6	returned	VBN	O	I-VP	O
22	7	to	TO	O	B-PP	O
22	8	the	DT	O	B-NP	O
22	9	patient	NN	O	I-NP	B-Medical
22	10	without	IN	O	B-PP	O
22	11	danger	NN	O	B-NP	O
22	12	of	IN	O	B-PP	O
22	13	immune	JJ	O	B-NP	B-Medical
22	14	rejection	NN	O	I-NP	O
22	15	.	.	O	O	O

23	0	But	CC	O	O	O
23	1	Mulligan	NNP	O	B-NP	O
23	2	fears	NNS	O	I-NP	O
23	3	that	IN	O	O	O
23	4	the	DT	O	B-NP	O
23	5	patient	NN	O	I-NP	B-Medical
23	6	's	POS	O	B-NP	O
23	7	own	JJ	O	I-NP	O
23	8	muscle	NN	O	I-NP	O
23	9	cells	NNS	O	I-NP	O
23	10	may	MD	O	B-VP	O
23	11	be	VB	O	I-VP	O
23	12	compromised	VBN	O	I-VP	O
23	13	in	IN	O	B-PP	O
23	14	some	DT	O	B-NP	O
23	15	way	NN	O	I-NP	O
23	16	and	CC	O	O	O
23	17	that	IN	O	O	O
23	18	``	``	O	O	O
23	19	there	EX	O	B-NP	O
23	20	's	VBZ	O	B-VP	O
23	21	a	DT	O	B-NP	O
23	22	far	RB	O	I-NP	O
23	23	greater	JJR	O	I-NP	O
23	24	hope	NN	O	I-NP	O
23	25	that	IN	O	O	O
23	26	if	IN	O	O	O
23	27	you	PRP	O	B-NP	O
23	28	make	VBP	O	B-VP	O
23	29	use	NN	O	B-NP	O
23	30	of	IN	O	B-PP	O
23	31	the	DT	O	B-NP	O
23	32	bone	NN	O	I-NP	O
23	33	marrow	NN	O	I-NP	O
23	34	compartment	NN	O	I-NP	O
23	35	you	PRP	O	B-NP	O
23	36	might	MD	O	B-VP	O
23	37	have	VB	O	I-VP	O
23	38	a	DT	O	B-NP	O
23	39	ready	JJ	O	I-NP	O
23	40	source	NN	O	I-NP	O
23	41	of	IN	O	B-PP	O
23	42	cells	NNS	O	B-NP	O
23	43	.	.	O	O	O
23	44	''	''	O	O	O

24	0	He	PRP	O	B-NP	O
24	1	envisages	NNS	O	B-NP	O
24	2	taking	VBG	O	B-VP	O
24	3	the	DT	O	B-NP	O
24	4	patient	NN	O	I-NP	B-Medical
24	5	's	POS	O	B-NP	O
24	6	bone	NN	O	I-NP	O
24	7	marrow	NN	O	I-NP	O
24	8	cells	NNS	O	I-NP	O
24	9	and	CC	O	O	O
24	10	trying	VBG	O	B-VP	O
24	11	to	TO	O	I-VP	O
24	12	repair	VB	O	I-VP	O
24	13	the	DT	O	B-NP	O
24	14	defective	JJ	O	I-NP	O
24	15	gene	NN	O	I-NP	O
24	16	.	.	O	O	O
